Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
5.91
-0.43 (-6.78%)
Apr 1, 2025, 4:00 PM EST - Market closed
Cybin Market Cap
Cybin has a market cap or net worth of $124.32 million as of April 1, 2025. Its market cap has decreased by -29.54% in one year.
Market Cap
124.32M
Enterprise Value
38.65M
1-Year Change
-29.54%
Ranking
Category
Stock Price
$5.91
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $124.32M, an increase of 36.47%. That is a compound annual growth rate of 7.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 133.37M | -24.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |